Central nervous system cancers, version 3.2020: NCCN Clinical Practice Guidelines in Oncology Guidelines


Authors: Nabors, L. B.; Portnow, J.; Ahluwalia, M.; Baehring, J.; Brem, H.; Brem, S.; Butowski, N.; Campian, J. L.; Clark, S. W.; Fabiano, A. J.; Forsyth, P.; Hattangadi-Gluth, J.; Holdhoff, M.; Horbinski, C.; Junck, L.; Kaley, T.; Kumthekar, P.; Loeffler, J. S.; Mrugala, M. M.; Nagpal, S.; Pandey, M.; Parney, I.; Peters, K.; Puduvalli, V. K.; Robins, I.; Rockhill, J.; Rusthoven, C.; Shonka, N.; Shrieve, D. C.; Swinnen, L. J.; Weiss, S.; Wen, P. Y.; Willmarth, N. E.; Bergman, M. A.; Darlow, S. D.
Title: Central nervous system cancers, version 3.2020: NCCN Clinical Practice Guidelines in Oncology
Abstract: The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 18
Issue: 11
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2020-11-01
Start Page: 1537
End Page: 1570
Language: English
DOI: 10.6004/jnccn.2020.0052
PUBMED: 33152694
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 December 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Thomas Kaley
    154 Kaley